Screening for Nephropathy in Pediatric Type 2 Diabetes: Quality Improvement to Increase Nephropathy Screening

Elizabeth A Mann1, Kelsi Alexander1, Whitney Beaton2

  • 1From the Department of Pediatrics, University of Wisconsin School of Medicine and Public Health, Madison, Wisc.

PubMed

Insights

Early screening for kidney disease in youth with type 2 diabetes is crucial. A quality improvement initiative successfully increased and sustained urine nephropathy screening rates in pediatric patients.

Area of Science:

  • Pediatric Nephrology
  • Endocrinology
  • Quality Improvement Science

Background:

  • Microalbuminuria screening is vital for early kidney disease detection in youth-onset type 2 diabetes.
  • Standardizing screening protocols is essential at the time of diagnosis.
  • A quality improvement initiative targeted pediatric type 2 diabetes patients at a tertiary academic medical center.

Purpose of the Study:

  • To standardize urine nephropathy screening in pediatric patients with type 2 diabetes.
  • To increase the baseline screening rate from 56% to 75% within 6 months.
  • To sustain the increased screening rate for an additional 6 months.

Main Methods:

  • Employed quality improvement methods and iterative Plan-Do-Study-Act cycles.
  • Implemented interventions including previsit planning, education, and a new-onset triage protocol.
  • Collected data through electronic medical record reviews, measuring screening rates at clinic visits.

Main Results:

  • Urine nephropathy screening rates increased from a baseline of 56% to 75%.
  • This significant increase was sustained for the subsequent 6-month period.
  • The study involved 121 youth with type 2 diabetes, with a mean age of 14.5 years.

Conclusions:

  • Interventions focused on efficient screening identification and coordinated processes improved screening rates.
  • Shared understanding among stakeholders and practical healthcare system support were key to success.
  • The initiative demonstrated sustained improvement in urine nephropathy screening for pediatric type 2 diabetes patients.
Abstract

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
524
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
265
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
86
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
921